NCT05346796 Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
| NCT ID | NCT05346796 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2022-09-09 |
| Primary Completion | 2027-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2022-09-09 with a primary completion date of 2027-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To understand the effectiveness and implementation of the SCP-PHR, we will conduct a hybrid type 1 effectiveness-implementation trial consisting of the following components: (A) a randomized clinical effectiveness trial, and (B) a mixed methods implementation study.
Eligibility Criteria
Inclusion Criteria: 1. Patients must be 18 years or older at the time of consent 2. Patients must have regular (at least weekly) access to an internet connection, whether at home or elsewhere (family or friend). 3. Diagnosis of colon or rectal cancer, Stages I, II, or III (AJCC, American Joint Committee on Cancer) and have undergone initial curative-intent therapy for their CRC diagnosis within the past 12 months. 4. English-speaking Exclusion Criteria: 1. Patient will be excluded if they have had recurrence of their colorectal cancer. 2. Patient's with severe cognitive impairment 3. Patient's with schizophrenia or other psychosis 4. Patients currently in hospice care
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05346796 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05346796 currently recruiting?
Yes, NCT05346796 is actively recruiting participants. Contact the research team at dahaggst@iu.edu for enrollment information.
Where is the NCT05346796 trial being conducted?
This trial is being conducted at Indianapolis, United States.
Who is sponsoring the NCT05346796 clinical trial?
NCT05346796 is sponsored by Indiana University. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.